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Single cell data explosion: Deep learning to the rescue 
The plethora of single-cell multi-omics data is getting treatment with deep learning, a 
revolutionary method in artificial intelligence, which has been increasingly expanding 
its reign over the bioscience frontiers. 
A.K.M. Azad & Fatemeh Vafaee* 
 
The traditional ‘bulk’ molecular 
profiling averages out information across 
different cell types within a population 
of millions of potentially heterogenous 
cells1. This composite measure masks 
individual variations among cells and 
limit our understanding on cell-specific 
functions2. In contrast, like a new 
magnifying lens, single-cell technology 
has enabled researchers to review 
biological hypotheses with high-
resolution insights zoomed at the single 
cell level, offering monumental 
opportunities in functional biology, 
precise diagnosis and precision therapy2. 
Single-cell data analysis can reconstruct 
continuous cell lineages, identify rare 
cell subtypes and predict novel cell 
types in a heterogeneous tissue3. It 
enables an understanding of an 
individual cell’s functions in the context 
of its micro-environment4, unmask 
variations between individual disease-
associated cells2, and facilitates the 
discovery of molecular signatures 
accounting for different cellular states1. 
Nonetheless, the enormously growing 
volume of single-cell data comes with 
several challenges, i.e., curse of 
dimensionality, sparsity, degree of 
noise, batch errors, and data 
heterogeneity5 which often hinder the 
performance of conventional 
computational approaches to scale up as 
data complexity and size grow, setting 
the stage for the contemporary deep 
learning algorithms. 
Deep learning, a powerful subfield of 
machine learning, is now captivating the 
recent hype in the artificial-intelligence 
industry through its promises in near-
human-level judgments. Following its 
remarkable achievements in the field of 
image recognition and natural language 
processing, deep learning is now 
effectively drawing the attentions of 
biotechnology researchers with a broad 
range of successful applications spanning 
from the biomarker discovery in medical 
images6 to predicting functions of non-
coding mutations in DNA sequences7. 
Architecturally, deep learning models 
have multi-layer artificial neural 
networks at their core, initially inspired 
by the structure and functions of the 
brain. In deep-learning networks, each 
layer consists of several nodes (i.e., 
computational units) coupled with a 
non-linear ‘activation’ function 
transforming large volume of input data 
into increasingly more abstract feature 
representations. The model is eventually 
trained by iterative parameter 
readjustments by relating those features 
with the known labels in order to make 
predictions on unseen data. Although 
training deep learning models possess 
computationally intensive operations for 
their numerous learnable parameters, 
Graphics processing units (GPUs) can be 
used to parallelize its major operations, 
i.e. the matrix multiplications required 
at their training phase8. 
The power of deep neural networks is in 
automatic feature learning from 
massive datasets which not only 
streamlines laborious manual feature 
selection but also facilitates learning 
task-optimal features8. They have 
achieved far better performance 
accuracies compared to classical 
machine learning methods in many 
complex data domains, with their 
performance scaling up effectively as 
data size grows. Overall, methods using 
deep-learning architectures can 
effectively deal with large-scale, 
heterogeneous and complex information 
which is specially demanded in the 
analysis of single-cell sequencing 
datasets9. 
Single-cell sequencing technologies can 
now simultaneously assay hundreds of 
thousands of individual cells provoking a 
“big data” phenomenon10. Moreover, for 
a more comprehensive understanding of 
cellular phenotypes, sequencing 
technologies are now offering 
simultaneous profiling of genome, 
epigenome, transcriptome, and 
proteome of an individual cell igniting 
further data explosion as single-cell 
multi-omics11. Processing and 
interpreting such high-dimensional 
single-cell information increasingly 
challenges conventional computational 
informatics12 calling for powerful and 
scalable deep learning models13 for 
dropout imputation, cell-subtype 
clustering, phenotype classification, 
visualization, and multi-omics 
integration (Figure 1).  
Exploring the “big” single cell data 
requires the reduction of its input 
dimensionality in order to visualize data 
in low-dimensional space in a scalable 
manner. A deep learning-based method, 
called Sparse Autoencoder for 
Unsupervised Clustering, Imputation, 
and Embedding (SAUCIE) has been used 
to reduce input dimension of single-cell 
data by successive applications of 
narrower layers5. The SAUCIE 
architecture also incorporates special 
layers for visualizing data in two-
dimensional space, removing batch-
effects, and automated data clustering5. 
Despite the data massiveness, single-cell 
data is often zero-inflated implying that 
more than 70% of read counts are 
frequently observed as either truly zeros 
or “dropouts” (false negatives)— 
typically caused by the technical failure 
to detect minute amounts of DNA/RNA 
present in a single cell14. This reduces 
data quality, imposes bias, and impedes 
effective downstream bioinformatic 
analyses14. More specifically, the 
dropout events may also result in near-
zero values for low-abundance genes, 
jeopardizing their confidence-levels for 
reliable statistical inference15. Several 
state-of-the-art imputation methods for 
single-cell data exists till date but major 
concerns remain with their long run-
time and memory consumptions in the 
context of single-cell big-data. 
DeepImpute, a deep learning-based 
approach claimed noticeable 
enhancements in these regards by 
employing a set of deep neural sub-
networks that lowers model complexity 
and over-fitting, with improved 
parallelism and enhanced accuracy 
among the competing methods14. 
Latterly, parallel profiling of multiple 
molecular types (e.g. DNA, chromatin, 
RNA and protein) of an individual cell 
has enabled an inclusive inference about 
cellular phenotypes and their 
associations with various diseases11. 
Integration of disparate multi-omics 
data poses various computational 
challenges, when properly addressed 
will impact medicine by enhancing 
health management as well as disease 
diagnosis and treatment16. Deep learning 
is an ideal model for multi-omics data 
integration17 with multiple success 
stories in integrating bulk profiles for 
prognosis prediction and precision 
medicine18,19, nourishing its prospect for 
integrating single-cell multi-omics 
data11.  
What makes deep learning usage more 
enriched is the availability of open-
source libraries, such as TensorFlow, 
Theano, Caffe, PyTorch or MXNet with 
varying degree of ease-of-use in defining 
and compiling deep neural network 
models and training or testing models on 
dataset. However, a major concern 
around deep learning methods is the 
‘black-box’ nature of the models and 
their un-interpretability due to the huge 
number of parameters and the complex 
approach for extracting and combining 
features. While data science community 
is active in enhancing interpretability of 
deep neural networks, further research 
in biomedical contexts are required to 
understand clinically or biologically 
relevant patterns in data raised to 
accurate predictions, and to improve 
the users’ trust ensuring that the model 
decides based on reliable reasons rather 
than artifacts in data20.   
Nevertheless, deep learning is a 
promisingly potent machine learning 
technology, and the ongoing research in 
this field are expected to reign over the 
recent “big bang” of single-cell multi-
omics data, just like it has been doing in 
other fields. 
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Figure 1: Deep learning is capable of offering multiple biological/clinical insights from single-cell multi-omics data  
